Akèy › Skleroz an milti pwogresif kwonik › Florid › Orlando
Etid klinik pou Skleroz an milti pwogresif kwonik nan Orlando, FL
4 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Ap rekriteFaz 4
- Neurology Associates, PA, Maitland · 6 mi lwen
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Neurology Associates, Maitland · 6 mi lwen
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Neurology Associates, PA, Maitland · 6 mi lwen
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Ap rekriteFaz 3
- Orlando Health Clinical Trials, Orlando
- Comprehensive Neurology Clinic, Orlando
- Neurology Associates PA, Maitland · 6 mi lwen
- ak 1 plis
Etid Skleroz an milti pwogresif kwonik nan lòt vil
- St. Louis, MO4 etid
- Chicago, IL4 etid
- Memphis, TN4 etid
- Kansas City, KS3 etid
- Tampa, FL3 etid
- Greenville, SC3 etid
- Scottsdale, AZ3 etid
- Burbank, CA3 etid
- Columbus, OH3 etid
Lòt etid nan Orlando
- Kansè Poumon ki pa ti selil44 etid
- Obèsite31 etid
- Kansè Metastatik29 etid
- Sipwa27 etid
- Maladi Alzheimer25 etid
- Dyabèt Tip 224 etid
- Kansè (tout kalite)24 etid
- Kolit Ulseratif23 etid
- Kansè nan tete23 etid
- Kansè ovè22 etid
- Kansè poumon21 etid
- Kansè kolorektal19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.